Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Metrics to compare | GRAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRANPeersSector | |
---|---|---|---|---|
P/E Ratio | 28.1x | 30.9x | −0.6x | |
PEG Ratio | 2.18 | 0.05 | 0.00 | |
Price/Book | 4.3x | 5.6x | 2.6x | |
Price / LTM Sales | 2.9x | 4.6x | 3.2x | |
Upside (Analyst Target) | 19.4% | −0.9% | 48.4% | |
Fair Value Upside | Unlock | −20.7% | 6.8% | Unlock |